Real-life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study.
J Eur Acad Dermatol Venereol
; 2023 Apr 16.
Article
in En
| MEDLINE
| ID: mdl-37062048
Full text:
1
Database:
MEDLINE
Type of study:
Clinical_trials
/
Observational_studies
Language:
En
Journal:
J Eur Acad Dermatol Venereol
Journal subject:
DERMATOLOGIA
/
DOENCAS SEXUALMENTE TRANSMISSIVEIS
Year:
2023
Type:
Article
Affiliation country:
Italy